![Dario N. R. Carrara](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dario N. R. Carrara
Chief Executive Officer at Amzell Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Alan Stephen Harris | M | - |
Amzell Ltd.
![]() Amzell Ltd. Pharmaceuticals: MajorHealth Technology Amzell Ltd. is a Dutch virtual development pharmaceutical company that specializes in taking candidate or repurposed drugs and devices through to proof of concept or registration for sale to commercial healthcare companies. The private company is based in Hoofddorp, Netherlands, and has subsidiaries in Switzerland. The company focuses on developing well-characterized active substances using innovative platform drug delivery technologies to provide more effective drug delivery, increased efficacy, and improved safety and compliance. One of their products, AMZ001, is a non-invasive topical gel formulation containing 3.06%% diclofenac sodium, which is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of pain related to knee osteoarthritis. The CEO of the company is Dario N. R. Carrara. | - |
Erik Henricus Maria Schropp | M | - |
Amzell Ltd.
![]() Amzell Ltd. Pharmaceuticals: MajorHealth Technology Amzell Ltd. is a Dutch virtual development pharmaceutical company that specializes in taking candidate or repurposed drugs and devices through to proof of concept or registration for sale to commercial healthcare companies. The private company is based in Hoofddorp, Netherlands, and has subsidiaries in Switzerland. The company focuses on developing well-characterized active substances using innovative platform drug delivery technologies to provide more effective drug delivery, increased efficacy, and improved safety and compliance. One of their products, AMZ001, is a non-invasive topical gel formulation containing 3.06%% diclofenac sodium, which is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of pain related to knee osteoarthritis. The CEO of the company is Dario N. R. Carrara. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert F. Apple | M | 58 | 16 years | |
Franklin Pass | M | 86 | 9 years | |
Eamonn Hobbs | M | 65 | 7 years | |
Leonard S. Jacob | M | 75 | 15 years | |
Kaushik J. Dave | M | 63 | 5 years | |
Jack Stover | M | 69 | 4 years | |
Jacques Gonella | M | 82 | 18 years | |
Paul Wotton | M | 63 | 10 years | |
Rajesh Shrotriya | M | 79 | - | |
Anton G. Gueth | M | 67 | 19 years | |
Thomas J. Garrity | M | 75 | 19 years | |
Lawrence M. Christian | M | 81 | 7 years | |
Keith Muckenhirn | M | 61 | 15 years | |
James Hattersley | M | 64 | - | |
Pavan Handa | M | - | - | |
Roger G. Harrison | M | 76 | 3 years | |
Patrick Madsen | M | - | 5 years | |
John Hayes | M | - | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 18 | 90.00% |
Netherlands | 2 | 10.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Dario N. R. Carrara
- Personal Network